Domov › Metastatická rakovina › Kolumbijský okres › Washington
Klinické štúdie Metastatická rakovina v meste Washington, DC
43 štúdií pre Metastatická rakovina hľadá účastníkov v zariadeniach v meste Washington a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Prebieha náborFáza 2
- Walter Reed National Military Medical Center, Bethesda · 7 míľ odtiaľ
- National Institutes of Health Clinical Center, Bethesda · 7 míľ odtiaľ
The Role of 68-Gallium-DOTATATE-PET/CT in the Imaging of Metastatic Thyroid Cancer
Prebieha náborFáza 2
- National Institutes of Health Clinical Center, Bethesda · 7 míľ odtiaľ
A Study of ASP3082 in Adults With Advanced Solid Tumors
Prebieha náborFáza 1
- Georgetown University Hospital, Washington D.C.
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
Prebieha náborFáza 2/3
- Georgetown University, Washington D.C.
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
Prebieha náborFáza 1
- Johns Hopkins Sibley Memorial Hospital, Washington D.C.
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
Prebieha náborFáza 2
- The George Washington Medical facility Associates, Washington D.C.
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Prebieha náborFáza 2/3
- Georgetown University Medical Center - Department of Pharmacy, Oncology Pharmacy, Washington D.C.
- Georgetown University Medical Center, Washington D.C.
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Prebieha náborFáza 3
- Maryland Oncology Hematology, P.A., Silver Spring · 7 míľ odtiaľ
- Maryland Oncology Hematology, P.A., Bethesda · 7 míľ odtiaľ
- Maryland Oncology Hematology, P.A., Largo · 11 míľ odtiaľ
A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
Prebieha náborFáza 1/2
- Georgetown University Medical Center, Washington D.C.
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Prebieha náborFáza 3
- MedStar Washington Hospital Center, Washington D.C.
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Prebieha náborFáza 3
- MedStar Washington Hospital Center, Washington D.C.
- American Oncology Partners, PA, Bethesda · 7 míľ odtiaľ
A Clinical Study of Ifinatamab Deruxtecan Based Treatment Combinations or as Monotherapy to Treat Metastatic Castrate Resistant Prostate Cancer (mCRPC) (MK-2400-01A/IDeate-Prostate02)
Prebieha náborFáza 1/2
- MedStar Georgetown Cancer Institute at MedStar Washington Hospital Center ( Site 0026), Washington D.C.
Testing How the Body Responds to the Drug CX-5461 (Pidnarulex) in Patients With Metastatic Solid Cancers
Prebieha náborFáza 1
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · 7 míľ odtiaľ
CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
Prebieha náborFáza 1/2
- Clinical Study Site, Washington D.C.
The Use of 124-I-PET/CT Whole Body and Lesional Dosimetry in Differentiated Thyroid Cancer
Prebieha náborFáza 2
- National Institutes of Health Clinical Center, Bethesda · 7 míľ odtiaľ
Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial
Prebieha náborFáza 2
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · 7 míľ odtiaľ
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Prebieha náborFáza 3
- Sibley Memorial Hospital, Washington D.C.
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Prebieha náborFáza 1/2
- Avenzo Therapeutics Recruiting Site, Washington D.C.
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Prebieha náborFáza 3
- The Center for Cancer and Blood Disorders a division of American Oncology Partners, P.A., Bethesda · 7 míľ odtiaľ
T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer
Prebieha náborFáza 2
- National Institutes of Health Clinical Center, Bethesda · 7 míľ odtiaľ
Testing the Combination of Two Anti-cancer Drugs, Peposertib (M3814) and Tuvusertib (M1774) for Advanced Solid Tumors
Prebieha náborFáza 1
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · 7 míľ odtiaľ
A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
Prebieha náborFáza 2
- Research Site, Washington D.C.
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Prebieha náborFáza 1/2
- Johns Hopkins University, Sibley Memorial Hospital, Washington D.C.
Testing How the Body Responds to the Drug CBX-12 in Patients With Advanced Solid Cancers
Prebieha náborFáza 1
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · 7 míľ odtiaľ
Studying the Safety and Determining the Optimal Dose of Novobiocin in Patients With Tumors That Have Alterations in DNA Repair Genes
Prebieha náborFáza 1
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · 7 míľ odtiaľ
Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness
Prebieha náborFáza 1/2
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · 7 míľ odtiaľ
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
Prebieha náborFáza 3
- Research Site, Washington D.C.
- Research Site, Silver Spring · 7 míľ odtiaľ
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
Prebieha náborFáza 1/2
- George Washington University, Washington D.C.
(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors
Prebieha náborFáza 3
- MedStar Washington Hospital Center, Washington D.C.
E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
Prebieha náborFáza 2
- National Institutes of Health Clinical Center, Bethesda · 7 míľ odtiaľ
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
Prebieha náborFáza 1/2
- Georgetown University Medical Center, Washington D.C.
Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)
Prebieha náborFáza 3
- American Oncology Partners, P.A., Bethesda · 7 míľ odtiaľ
Studying TAK-243 in Patients With Advanced Cancer
Prebieha náborFáza 1
- National Cancer Institute Developmental Therapeutics Clinic, Bethesda · 7 míľ odtiaľ
Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
Prebieha náborFáza 2/3
- The Center for Cancer and Blood Disorders, Bethesda · 7 míľ odtiaľ
Cancer Experience Registry (CER) for Cancer Patients and Caregivers
Prebieha náborObservačná štúdiaVítaní zdravých dobrovoľníkov
- Cancer Support Community Research & Training Institute, Washington D.C.
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
Prebieha náborFáza 3
- The George Washington University, Washington D.C.
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
Prebieha náborFáza 2/3
- Washington DC VA Medical Center, Washington, DC, Washington D.C.
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
Prebieha náborFáza 2/3
- Georgetown University Medical Center, Washington D.C.
Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors
Prebieha náborFáza 1
- National Cancer Institute, Bethesda · 7 míľ odtiaľ
A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)
Prebieha náborFáza 1
- Georgetown University Medical Center, Washington D.C.
- Sibley Memorial Hospital, Washington D.C.
Evaluation of RBS2418 in Subjects With Advanced, Metastatic Solid Tumors
Prebieha náborFáza 1
- American Oncology Partners of Maryland, Bethesda · 7 míľ odtiaľ
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
Prebieha náborFáza 1/2
- The George Washington University Cancer Center (site 212), Washington D.C.
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Prebieha náborObservačná štúdia
- Massive Bio SYNERGY-AI site, Silver Spring · 7 míľ odtiaľ
- Massive Bio SYNERGY-AI site, Bethesda · 7 míľ odtiaľ
Štúdie Metastatická rakovina v iných mestách
- Houston, TX104 štúdií
- New York City, NY93 štúdií
- Nashville, TN70 štúdií
- Boston, MA63 štúdií
- Los Angeles, CA57 štúdií
- St. Louis, MO54 štúdií
- Arlington, VA53 štúdií
- Philadelphia, PA46 štúdií
- Chicago, IL45 štúdií
- San Antonio, TX44 štúdií
- Dallas, TX42 štúdií
- Seattle, WA39 štúdií
Iné štúdie v Washington
- Rakovina (všetky typy)58 štúdií
- Nemalobunkový karcinóm pľúc55 štúdií
- Rakovina prsníka46 štúdií
- Rakovina pľúc41 štúdií
- Rakovina prostaty38 štúdií
- Obézita33 štúdií
- Kolorektálny karcinóm29 štúdií
- Kardiovaskulárne ochorenia28 štúdií
- Rakovina močového mechúra26 štúdií
- Akútna myeloidná leukémia24 štúdií
- Rakovina vaječníkov23 štúdií
- Lymfóm23 štúdií
Z ClinicalTrials.gov, dáta načítané 6. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.